The l58Val/Met polymorphism of catechol-O-methyl transferase gene and prostate cancer risk: A meta-analysis

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 1835-1841

  Xiao, Li ^a   Tong, Ming ^a   Jin, Yanyang ^a   Huang, Weichao ^a   Li, Zizhi ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Catechol O methyl transferase; Meta analysis; Polymorphism; Prostate cancer

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ARTICLE; CANCER RISK; COMT GENE; ETHNICITY; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 84878364734     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2238-z     Document Type: Article

References (13)

1. Lotta T, Vidgren J, Tilgmann C et al (1995) Kinetics of human soluble and membrane-bound Catechol O-Methyl transferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210
2. Suzuki K, Nakazato H, Matsui H, Koike H, Okugi H, Kashiwagi B et al (2003) Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population. Cancer 98(7):1411-1416
3. Nock NL, Cicek MS, Li L et al (2006) Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis vol 27:1842-1848
4. Cussenot O, Azzouzi AR, Nicolaiew N et al (2007) Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. J Clin Oncol 25:3596-3602
5. Suzuki M, Kurosaki T, Arai T et al (2007) The Val158Met polymorphism of the catechol-O-methyltransferase gene is not associated with the risk of sporadic or latent prostate cancer in Japanese men. Int J Urol 14:800-804
6. Omrani MD, Bazargani S, Bagheri M et al (2009) Association of catechol-o-methyl transferase gene polymorphism with prostate cancer and benign prostatic hyperplasia. J Res Med Sci 14(4):217-222
7. Tanaka Y, Sasaki M, Shiina H et al (2006) Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer. Cancer Epidemiol Biomarkers Prev 15:238-244
8. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
9. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
10. Fujisawa T, Ikegami H, Kawaguchi Y et al (1998) Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41(1):47-53
11. Wedrén S, Rudqvist TR, Granath F, Weiderpass E, Ingelman-Sundberg M, Persson I et al (2003) Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk. Carcinogenesis 24(4):681-687
12. McGrath M, Hankinson SE, Arbeitman L, Colditz GA, Hunter DJ, De Vivo I (2004) Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility. Carcinogenesis 25(4):559-565
13. Doherty JA, Weiss NS, Freeman RJ, Dightman DA, Thornton PJ, Houck JR et al (2005) Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 14(2):357-366